Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
250.00    0.00 (0.00%)
Bid:
245.00
Ask:
255.00
Spread: 10.00 (4.082%)
Market Cap: £227.11m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Board Changes

12 May 2021 09:00

RNS Number : 2860Y
Concurrent Technologies PLC
12 May 2021
 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a Regulatory Information Service, this information is considered to be in the public domain

 

12 May 2021

 

Concurrent Technologies Plc

 

Board Changes

 

Concurrent Technologies Plc (AIM: CNC), a world leading specialist in the design and manufacture of high-performance embedded computer boards for critical applications, is pleased to announce the appointment of Dr Miles Adcock as Chief Executive Officer and as an executive director of the Company with effect from 21 June 2021.

 

The Company also announces today that Jane Annear, Managing Director, has given notice of her retirement after 36 years of outstanding service to the Company. Jane will work to support Miles in her remaining time with the Company in order to ensure an orderly transition and will continue as an executive director of the Company during that time.

 

Dr Miles Adcock is currently President of Space Imaging at Teledyne Technologies Inc. Prior to joining Teledyne, Miles held senior roles at QinetiQ Group plc including as Managing Director of its Cyber, Information & Training business unit and as Group Engineering Director. He has previously worked at BAE Systems and GEC Marconi. A Chartered Engineer and a Chartered Physicist, he received his PhD in Adaptive Optics from Imperial College, London.

 

Mark Cubitt, Non-executive Chairman of Concurrent Technologies, commented:

 

"We are delighted to welcome Miles as Chief Executive Officer of Concurrent Technologies. His experience in growing international based technology companies will help drive forward the Company to take the next steps in our development as a leading player in the high performance embedded market. It is also important we recognise today the significant role Jane has played in the growth of the Company, which she has served since she joined as our second employee on incorporation in 1985."

 

Dr Miles Adcock commented:

 

"I am very pleased to take up this role. Concurrent Technologies is a fantastic organisation. We have great people and technological capabilities and a competitive customer offering. I look forward to leading Concurrent Technologies in its next phase of growth and creating value for all our stakeholders."

 

Jane Annear, Managing Director, commented:

 "It has been a privilege to lead the team at Concurrent Technologies for the last 2 years and I would like to thank all of our employees for their commitment and support during that time. I am pleased to welcome Miles to the role of Chief Executive Officer in a new and exciting era for the Company."

 

 

 

 

Enquiries:

 

Concurrent Technologies PlcJane Annear, Managing Director

 

+44 (0)1206 752626

Newgate (Financial PR)Bob Huxford

Isabelle Smurfit

 

+44 (0)20 7653 9848+44 (0)20 3757 3411

Cenkos Securities Plc (NOMAD)Neil McDonald

Peter Lynch

+44 (0)131 220 9771

+44 (0)131 220 9772

 

The following information regarding the appointment of Dr Miles Adcock (aged 48) is required to be disclosed under Schedule 2(g) of the AIM Rules for Companies:

 

Full Name:

Miles John Adcock

 

Current Directorship / Partnerships:

South East LEP Limited

Teledyne e2v Ltd

Teledyne UK Limited

 

Previous Directorship / Partnerships:

BJ Trustee Limited

Bolden James Limited

Cuesim Limited

Gyldan 11 Limited

Leading Technology Limited

Qinetiq Special Project Inc.

 

There are no further disclosures to be made under Schedule 2(g) of the AIM Rules for Companies.

 

Note to Editors:

 

About Concurrent Technologies Plc

 

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high performance, long life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest 9th generation embedded Intel® Core™ processors, Intel® Xeon® and Intel Atom® processors. The products are designed to be compliant with industry specifications and support many of today's leading embedded Operating Systems. The products are sold world-wide.

 

For more information on Concurrent Technologies Plc and its products please visit www.gocct.com.

 

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAKSFFFLFEFA
Date   Source Headline
19th Sep 20075:27 pmRNSDirector/PDMR Shareholding
19th Sep 20077:00 amPRNInterim Results
18th Sep 20072:56 pmPRNProduct Launch
11th Sep 200712:38 pmPRNNotice of Interim Results
6th Sep 200710:33 amPRNProduct Launch
28th Aug 20073:35 pmPRNProduct Launch
17th Aug 20073:22 pmRNSAIM Rule 26
8th Aug 20074:45 pmRNSHolding(s) in Company
31st Jul 20079:08 amRNSTotal Voting Rights
20th Jul 200710:55 amPRNProduct Launch
6th Jul 20074:17 pmRNSTransaction in Own Shares
27th Jun 20074:06 pmRNSDirector/PDMR Shareholding
19th Jun 20079:06 amRNSDirector/PDMR Shareholding
1st Jun 20073:53 pmPRNProduct Launch
23rd May 200711:10 amRNSHolding(s) in Company
15th May 20075:43 pmRNSHolding(s) in Company
18th Apr 200711:17 amPRNProduct Launch
23rd Mar 20075:05 pmRNSHolding(s) in Company
22nd Mar 20074:25 pmRNSHolding(s) in Company
22nd Mar 20074:19 pmRNSHolding(s) in Company
22nd Mar 20077:00 amPRNStatement re Vendor Rating Award
20th Mar 20075:45 pmRNSHolding(s) in Company
19th Mar 20077:00 amPRNFinal Results
13th Mar 20072:28 pmPRNProduct Launch
9th Mar 20074:39 pmRNSHolding(s) in Company
6th Mar 200710:51 amPRNNotice of Results
23rd Feb 20073:32 pmRNSHolding(s) in Company
15th Feb 20074:52 pmPRNProduct Launch
6th Feb 20073:13 pmRNSChange of Registered Office
30th Jan 200710:57 amPRNProduct Launch
26th Jan 20079:11 amPRNProduct Launch
22nd Dec 200611:55 amRNSAdditional Listing
21st Dec 20064:44 pmRNSTotal Voting Rights
18th Dec 20069:59 amPRNTrading Statement
11th Dec 20067:00 amPRNProduct Launch
5th Dec 20062:22 pmRNSTransaction in Own Shares
27th Nov 20063:14 pmRNSTransaction in Own Shares
23rd Nov 200611:57 amRNSTransaction in Own Shares
21st Nov 20064:55 pmRNSTransaction in Own Shares
14th Nov 20063:56 pmRNSTransaction in Own Shares
13th Oct 20063:45 pmRNSHolding(s) in Company
27th Sep 20065:06 pmRNSTransaction in Own Shares
18th Sep 20064:11 pmRNSDirector/PDMR Shareholding
13th Sep 200611:34 amPRNDirector/PDMR Shareholding
12th Sep 20067:00 amPRNInterim Results
8th Sep 20067:00 amPRNStaff appointment
21st Jul 20067:00 amPRNProduct Launch
28th Jun 200611:04 amRNSDirector/PDMR Shareholding
27th Jun 200612:00 pmPRNTrading Statement
22nd May 20062:03 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.